129 related articles for article (PubMed ID: 15133508)
1. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells.
Hou WS; Van Parijs L
Nat Immunol; 2004 Jun; 5(6):583-9. PubMed ID: 15133508
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the lifespan in dendritic cell subsets.
Chen M; Huang L; Shabier Z; Wang J
Mol Immunol; 2007 Apr; 44(10):2558-65. PubMed ID: 17267035
[TBL] [Abstract][Full Text] [Related]
3. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
[TBL] [Abstract][Full Text] [Related]
4. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed TH1/TH2-like cytokine response by naive CD4+ T cells.
Williams MA; Porter M; Horton M; Guo J; Roman J; Williams D; Breysse P; Georas SN
J Allergy Clin Immunol; 2007 Feb; 119(2):488-97. PubMed ID: 17187851
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
[TBL] [Abstract][Full Text] [Related]
6. Decoding the dynamics of T cell-dendritic cell interactions in vivo.
Celli S; Garcia Z; Beuneu H; Bousso P
Immunol Rev; 2008 Feb; 221():182-7. PubMed ID: 18275482
[TBL] [Abstract][Full Text] [Related]
7. Balancing life and death.
Moser M
Nat Immunol; 2004 Jun; 5(6):559-60. PubMed ID: 15164011
[No Abstract] [Full Text] [Related]
8. 1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells.
Decallonne B; van Etten E; Overbergh L; Valckx D; Bouillon R; Mathieu C
J Autoimmun; 2005 Jun; 24(4):281-9. PubMed ID: 15913954
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
10. 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.
Kim JH; Chen J; Majumder N; Lin H; Falo LD; You Z
Gene Ther; 2005 Oct; 12(20):1517-25. PubMed ID: 16052205
[TBL] [Abstract][Full Text] [Related]
11. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.
Yang J; Huck SP; McHugh RS; Hermans IF; Ronchese F
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):147-52. PubMed ID: 16373503
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell subsets and toll-like receptors.
Hochrein H; O'Keeffe M
Handb Exp Pharmacol; 2008; (183):153-79. PubMed ID: 18071659
[TBL] [Abstract][Full Text] [Related]
13. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency.
Yoshikawa T; Niwa T; Mizuguchi H; Okada N; Nakagawa S
Gene Ther; 2008 Oct; 15(19):1321-9. PubMed ID: 18480845
[TBL] [Abstract][Full Text] [Related]
14. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity.
Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B
Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744
[TBL] [Abstract][Full Text] [Related]
15. Differences in expression of cell surface co-stimulatory molecules, Toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii.
Awasthi S; Magee DM
Cell Immunol; 2004; 231(1-2):49-55. PubMed ID: 15919369
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
17. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
18. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
19. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes.
Haenssle H; Buhl T; Knudsen S; Krueger U; Rosenberger A; Reich K; Neumann C
Exp Dermatol; 2008 Mar; 17(3):177-87. PubMed ID: 18081852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
